HFA
TAK icon

Hoover Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Hoover Financial Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$9K Hold
545
– – ﹤0.01% 493
2021
Q1 		$9K Hold
545
– – ﹤0.01% 443
2020
Q4 		$10K Buy
+545
New +$9.56K ﹤0.01% 409
2020
Q3 		– Sell
-545
Closed -$10K – 436
2020
Q2 		$10K Buy
+545
New +$9.78K ﹤0.01% 347

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hoover Financial Advisors's TAK Position: Q2 2021 in Review

Hoover Financial Advisors held its Takeda Pharmaceutical (TAK) position steady in Q2 2021 at 545 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Hoover Financial Advisors first reported a position in TAK in Q2 2020 and has held it in 4 quarters since. The position peaked at $10K in Q4 2020. 305 funds tracked by Wall St. Rank hold TAK as of Q2 2021.

  • Hoover Financial Advisors held 545 shares of Takeda Pharmaceutical worth $9K as of Q2 2021.
  • Hoover Financial Advisors left its Takeda Pharmaceutical share count unchanged in Q2 2021.
  • Takeda Pharmaceutical made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #493 holding.
  • Hoover Financial Advisors first reported a position in Takeda Pharmaceutical in Q2 2020 and has held it in 4 quarters since.
  • Hoover Financial Advisors's Takeda Pharmaceutical position peaked at $10K in Q4 2020.
  • 305 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.